ArticlePharmaceutical research2012

Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats.

Ji-Eun Chang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.